These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 19479807)

  • 1. Graft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: a case series.
    Tan HH; Fiel MI; del Rio Martin J; Schiano TD
    Liver Transpl; 2009 Jun; 15(6):634-9. PubMed ID: 19479807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late acute rejection after liver transplantation impacts patient survival.
    Uemura T; Ikegami T; Sanchez EQ; Jennings LW; Narasimhan G; McKenna GJ; Randall HB; Chinnakotla S; Levy MF; Goldstein RM; Klintmalm GB
    Clin Transplant; 2008; 22(3):316-23. PubMed ID: 18190550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.
    Fiel MI; Agarwal K; Stanca C; Elhajj N; Kontorinis N; Thung SN; Schiano TD
    Liver Transpl; 2008 Jun; 14(6):861-71. PubMed ID: 18508382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.
    Venkat VL; Nick TG; Wang Y; Bucuvalas JC
    Pediatr Transplant; 2008 Feb; 12(1):67-72. PubMed ID: 18186891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
    Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
    Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients.
    Urbani L; Mazzoni A; Catalano G; De Simone P; Vanacore R; Pardi C; Bortoli M; Biancofiore G; Campani D; Perrone V; Mosca F; Scatena F; Filipponi F
    Transplant Proc; 2004 Dec; 36(10):3068-70. PubMed ID: 15686696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.
    Heneghan MA; Portmann BC; Norris SM; Williams R; Muiesan P; Rela M; Heaton ND; O'Grady JG
    Hepatology; 2001 Sep; 34(3):464-70. PubMed ID: 11526530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation.
    Gibelli NE; Tannuri U; Mello ES; Cançado ER; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Pinho-Apezzato ML; Maksoud JG
    Pediatr Transplant; 2006 May; 10(3):371-6. PubMed ID: 16677364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late acute liver allograft rejection; a study of its natural history and graft survival in the current era.
    Thurairajah PH; Carbone M; Bridgestock H; Thomas P; Hebbar S; Gunson BK; Shah T; Neuberger J
    Transplantation; 2013 Apr; 95(7):955-9. PubMed ID: 23442806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver disease recurrence after liver transplantation].
    Rakela B J
    Rev Med Chil; 2010 Apr; 138(4):504-10. PubMed ID: 20668801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence.
    Nakhleh RE; Krishna M; Keaveny AP; Dickson RC; Rosser B; Nguyen JH; Steers JL
    Transplant Proc; 2005 Mar; 37(2):1240-2. PubMed ID: 15848682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking behavior in liver transplant recipients.
    van der Heide F; Dijkstra G; Porte RJ; Kleibeuker JH; Haagsma EB
    Liver Transpl; 2009 Jun; 15(6):648-55. PubMed ID: 19479809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone disease in liver transplant recipients: incidence, timing, and risk factors.
    Porayko MK; Wiesner RH; Hay JE; Krom RA; Dickson ER; Beaver S; Schwerman L
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1462-5. PubMed ID: 1989266
    [No Abstract]   [Full Text] [Related]  

  • 20. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
    Alabraba E; Nightingale P; Gunson B; Hubscher S; Olliff S; Mirza D; Neuberger J
    Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.